Sana Biotechnology, Inc. (SANA) stock forecast and price target
Price $2.02 · data as of November 13, 2026
12-month price target
Average target$8.57
Upside / downside+324.3%
Analysts7
ConsensusStrong buy
Low $6.00Average $8.57High $13.00
Gold marker: average target · white marker: today’s price ($2.02)
Analyst ratings
Strong buy 2Buy 6Hold 1Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.49 | +26.7% | $0 |
| Next fiscal year ends December 31, 2027 | $-0.44 | +10.9% | $0 |
| Next quarter ends December 31, 2026 | $-0.14 | +15.5% | $0 |
| Quarter after ends March 31, 2027 | $-0.10 | +28.6% | $0 |
Consensus of the analysts covering Sana Biotechnology, updated daily. In the last 30 days 2 estimates were raised and 2 lowered.
Frequently asked questions
What is the Sana Biotechnology stock price target?
The average 12-month target from 7 analysts is $8.57, 324.3% above the current price of $2.02 Targets range from $6.00 to $13.00.
Is Sana Biotechnology a buy according to analysts?
The consensus rating is “Strong buy” (2 strong buy, 6 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Sana Biotechnology expected to earn?
Analysts expect EPS of $-0.49 for the fiscal year ending December 31, 2026 and $-0.44 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.